These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22891541)

  • 1. [Capsaicin and lidocaine usage in functional disorders of urinary bladder].
    Juszczak K; Thor PJ
    Folia Med Cracov; 2011; 51(1-4):91-8. PubMed ID: 22891541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intravesical treatment of overactive bladder syndrome].
    Haferkamp A; Hohenfellner M
    Urologe A; 2006 Oct; 45(10):1283-8. PubMed ID: 16972089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urodynamic effects of the bladder C-fiber afferent activity modulation in chronic model of overactive bladder in rats.
    Juszczak K; Ziomber A; Wyczolkowski M; Thor PJ
    J Physiol Pharmacol; 2009 Dec; 60(4):85-91. PubMed ID: 20065501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quaternary Lidocaine Derivative QX-314 Activates and Permeates Human TRPV1 and TRPA1 to Produce Inhibition of Sodium Channels and Cytotoxicity.
    Stueber T; Eberhardt MJ; Hadamitzky C; Jangra A; Schenk S; Dick F; Stoetzer C; Kistner K; Reeh PW; Binshtok AM; Leffler A
    Anesthesiology; 2016 May; 124(5):1153-65. PubMed ID: 26859646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of urinary bladder innervation: TRPV1 and botulinum toxin A.
    Charrua A; Avelino A; Cruz F
    Handb Exp Pharmacol; 2011; (202):345-74. PubMed ID: 21290235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The basic neurophysiologic concept of lower urinary tract function--the role of vanilloid TRPV1 receptors of urinary bladder afferent nerve endings.
    Juszczak K; Thor PJ
    Adv Clin Exp Med; 2012; 21(4):417-21. PubMed ID: 23240446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of partial and complete blockade of vanilloid (TRPV1-6) and ankyrin (TRPA1) transient receptor potential ion channels on urinary bladder motor activity in an experimental hyperosmolar overactive bladder rat model.
    Juszczak K; Ziomber A; Thor PJ
    J Physiol Pharmacol; 2011 Jun; 62(3):321-6. PubMed ID: 21893692
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute Intravesical Capsaicin for the Study of TRPV1 in the Lower Urinary Tract: Clinical Relevance and Potential for Innovation.
    Andersson KE; Behr-Roussel D; Denys P; Giuliano F
    Med Sci (Basel); 2022 Sep; 10(3):. PubMed ID: 36135835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The concept of neurogenic inflammation.
    Geppetti P; Nassini R; Materazzi S; Benemei S
    BJU Int; 2008 Mar; 101 Suppl 3():2-6. PubMed ID: 18307678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravesical therapy for overactive bladder.
    Evans RJ
    Curr Urol Rep; 2005 Nov; 6(6):429-33. PubMed ID: 16238916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the origin of bladder sensing: Tr(i)ps in urology.
    Everaerts W; Gevaert T; Nilius B; De Ridder D
    Neurourol Urodyn; 2008; 27(4):264-73. PubMed ID: 17849480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of 1% Lidocaine Instillation on Overactive Bladder Induced by Bladder Outlet Obstruction in Rats.
    Kang HJ; Kim SW; Lee YS; Han SW; Kim JH
    Urol J; 2020 May; 17(3):306-311. PubMed ID: 31630385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Irritant-induced chronic cough: irritant-induced TRPpathy.
    Brooks SM
    Lung; 2008; 186 Suppl 1():S88-93. PubMed ID: 18239961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms involved in new therapies for overactive bladder.
    Cruz F
    Urology; 2004 Mar; 63(3 Suppl 1):65-73. PubMed ID: 15013655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatments for overactive bladder: focus on pharmacotherapy.
    Geoffrion R;
    J Obstet Gynaecol Can; 2012 Nov; 34(11):1092-1101. PubMed ID: 23231848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electromotive drug-administration: a pilot study for minimal-invasive treatment of therapy-resistant idiopathic detrusor overactivity.
    Bach P; Wormland RT; Möhring C; Goepel M
    Neurourol Urodyn; 2009; 28(3):209-13. PubMed ID: 19205067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of botulinum toxin on expression of nerve growth factor and transient receptor potential vanilloid 1 in urothelium and detrusor muscle of rats with bladder outlet obstruction-induced detrusor overactivity.
    Ha US; Park EY; Kim JC
    Urology; 2011 Sep; 78(3):721.e1-721.e6. PubMed ID: 21782224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the transient receptor potential (TRP) superfamily of cation-selective channels in the management of the overactive bladder.
    Andersson KE; Gratzke C; Hedlund P
    BJU Int; 2010 Oct; 106(8):1114-27. PubMed ID: 21156013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin A for the Treatment of Overactive Bladder.
    Hsieh PF; Chiu HC; Chen KC; Chang CH; Chou EC
    Toxins (Basel); 2016 Feb; 8(3):. PubMed ID: 26938559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developments in the pharmacotherapy of the overactive bladder.
    Sellers DJ; McKay N
    Curr Opin Urol; 2007 Jul; 17(4):223-30. PubMed ID: 17558263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.